InVivo Therapeutics adds a 3rd clinical site to a feasibility study of its biodegradable implant to treat acute spinal cord injuries.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1D20lZp
Cap comentari:
Publica un comentari a l'entrada